Sharon Travels and Talks!
Dr. Diskin has been quite busy this Spring! In addition to her teaching GCB/CAMB 752 Seminar in Genomics, and leading her lab, she has been traveling all over speaking. Between the first week of March and early May, Sharon traveled to Washington DC, Frederick MD, San Francisco CA, Cambridge UK, and ending with Boston MA! Here is a glimpse:
March 7: She presented “An integrative proteogenomic approach identifies DLK1 as an oncoprotein and target for immunotherapy in high-risk neuroblastoma” at the US HUPO (United States Human Proteomics) Meeting.
March 28: Sharon gave a seminar entitled “Genetic Predisposition to Neuroblastoma: From Discovery to Translational Opportunities” at the National Cancer Institute’s Pediatric Oncology Branch.
April 5: In San Francisco at the UCSF Helen Diller Family Comprehensive Cancer Center Seminar, Sharon gave a lecture “Unraveling the Genetic Basis of Neuroblastoma: From Discovery to Clinical Implications”.
April 12th: Dr. Diskin was the invited speaker at the 5th Neuroblastoma United Kingdom (NBUK) Research Symposium at Cambridge. Her talk there was titled “Multi-omic surfaceome study identifies DLK1 as a candidate oncoprotein and immunotherapeutic target in neuroblastoma.”
May 7th: Her final trip of the Spring was to the Dana Farber Cancer Research Institute as part of their Seminars in Oncology series, her lecture was titled “Insights into neuroblastoma genetics and immunotherapy target identification revealed through integrative multi-omic approaches.”
A whirlwind of a Spring, for certain!